1. Home
  2. GOOS vs LQDA Comparison

GOOS vs LQDA Comparison

Compare GOOS & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GOOS
  • LQDA
  • Stock Information
  • Founded
  • GOOS 1957
  • LQDA 2004
  • Country
  • GOOS Canada
  • LQDA United States
  • Employees
  • GOOS N/A
  • LQDA N/A
  • Industry
  • GOOS
  • LQDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • GOOS
  • LQDA Health Care
  • Exchange
  • GOOS Nasdaq
  • LQDA Nasdaq
  • Market Cap
  • GOOS 1.1B
  • LQDA 1.2B
  • IPO Year
  • GOOS 2017
  • LQDA 2018
  • Fundamental
  • Price
  • GOOS $14.04
  • LQDA $14.51
  • Analyst Decision
  • GOOS Hold
  • LQDA Strong Buy
  • Analyst Count
  • GOOS 5
  • LQDA 9
  • Target Price
  • GOOS $11.25
  • LQDA $27.67
  • AVG Volume (30 Days)
  • GOOS 1.0M
  • LQDA 2.0M
  • Earning Date
  • GOOS 07-31-2025
  • LQDA 08-06-2025
  • Dividend Yield
  • GOOS N/A
  • LQDA N/A
  • EPS Growth
  • GOOS 70.17
  • LQDA N/A
  • EPS
  • GOOS 0.68
  • LQDA N/A
  • Revenue
  • GOOS $943,742,214.00
  • LQDA $14,144,000.00
  • Revenue This Year
  • GOOS $4.27
  • LQDA $189.27
  • Revenue Next Year
  • GOOS $5.83
  • LQDA $402.79
  • P/E Ratio
  • GOOS $20.19
  • LQDA N/A
  • Revenue Growth
  • GOOS 1.09
  • LQDA N/A
  • 52 Week Low
  • GOOS $6.73
  • LQDA $8.26
  • 52 Week High
  • GOOS $14.28
  • LQDA $19.41
  • Technical
  • Relative Strength Index (RSI)
  • GOOS 74.49
  • LQDA 55.41
  • Support Level
  • GOOS $13.54
  • LQDA $11.86
  • Resistance Level
  • GOOS $14.28
  • LQDA $14.99
  • Average True Range (ATR)
  • GOOS 0.50
  • LQDA 0.72
  • MACD
  • GOOS 0.20
  • LQDA 0.30
  • Stochastic Oscillator
  • GOOS 91.91
  • LQDA 84.71

About GOOS Canada Goose Holdings Inc. Subordinate Voting Shares

Canada Goose Holdings Inc is a Canada-based company that designs, manufactures, distributes, and retails premium outerwear for men, women, and children. It operates business through three segments namely, Wholesale and Direct to Consumer (DTC), Other. The DTC segment, which is the key revenue driver, comprises sales through country-specific e-commerce platforms and its company-owned retail stores located in luxury shopping locations. The Wholesale segment comprises sales made to a mix of retailers and international distributors, who are partners that have exclusive rights to an entire market, and travel retail locations. Geographically, it has a presence in Canada, the United States, North America, Greater China, Asia, and Europe, the Middle East, and Africa.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

Share on Social Networks: